Literature DB >> 27502293

Quantitative assessment of the entire right ventricle from one acoustic window: an attractive approach.

Jackie S McGhie, Myrthe E Menting, Wim B Vletter, René Frowijn, Jolien W Roos-Hesselink, Heleen B van der Zwaan, Osama I I Soliman, Marcel L Geleijnse, Annemien E van den Bosch.   

Abstract

AIMS: The aim of this prospective study was to evaluate the feasibility and establish normal values of functional right ventricle (RV) parameters as assessed in our four, long-axis view RV model using iRotate echocardiography. Furthermore, we evaluated the potential use of this model in patients with abnormally loaded RVs. METHOD AND
RESULTS: One hundred and fifty-five healthy subjects aged 20-72 years (≥28 subjects per decile) were prospectively recruited. We used non-dedicated RV speckle-tracking software to test the feasibility and to establish normal range values of peak systolic global longitudinal RV strain (RV-GLS) from the RV free-walls (septum was excluded). Also normal range values for: dimensions, tricuspid annular plane systolic excursion (TAPSE) and tricuspid annular peak systolic velocity (TDI-S') were established. The feasibility of RV-GLS was 88, 84, and 62%, respectively, in the lateral, inferior, and anterior free wall. Mean RV-GLS normal values were -24.5 ± 4.9% for lateral wall and -25.4 ± 5.0% for anterior wall. Mean RV-GLS in the inferior wall was -23.2 ± 4.4% in the aortic (Ao) view and -20.7 ± 5.0% in the coronal (CV) view. The feasibility of mean RV-GLS was 100% in the anterior, lateral, and inferior walls in abnormally dilated RVs.
CONCLUSION: The feasibility of all RV parameters assessed in the four-view iRotate model is good to excellent. Normal values for RV dimension and function of the anterior, inferior, and lateral RV walls have been established. Further studies and dedicated RV speckle-tracking software are warranted to discover the full potential of this new technique. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  echocardiography; multi-view strain; right ventricle

Mesh:

Year:  2017        PMID: 27502293     DOI: 10.1093/ehjci/jew165

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  5 in total

1.  Defining the reference range for right ventricular systolic strain by echocardiography in healthy subjects: A meta-analysis.

Authors:  Tom Kai Ming Wang; Richard A Grimm; L Leonardo Rodriguez; Patrick Collier; Brian P Griffin; Zoran B Popović
Journal:  PLoS One       Date:  2021-08-20       Impact factor: 3.240

2.  Transhepatic echocardiography: a novel approach for imaging in left ventricle assist device patients with difficult acoustic windows.

Authors:  Mihai Strachinaru; Daniel J Bowen; Alina Constatinescu; Olivier C Manintveld; Jasper J Brugts; Marcel L Geleijnse; Kadir Caliskan
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-05-01       Impact factor: 6.875

3.  Left ventricular strain values using 3D speckle-tracking echocardiography in healthy adults aged 20 to 72 years.

Authors:  Ferit Onur Mutluer; Daniel J Bowen; Roderick W J van Grootel; Jolien W Roos-Hesselink; Annemien E Van den Bosch
Journal:  Int J Cardiovasc Imaging       Date:  2020-11-23       Impact factor: 2.357

4.  Multi-plane echocardiographic assessment of right ventricular function in adults with repaired Tetralogy of Fallot.

Authors:  Daniel J Bowen; An M van Berendoncks; Jackie S McGhie; Jolien W Roos-Hesselink; Annemien E van den Bosch
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-18       Impact factor: 2.357

5.  Right ventricular functional assessment by 2D multi-plane echocardiography prior to left ventricular assist device implantation.

Authors:  Daniel J Bowen; Yunus C Yalcin; Mihai Strachinaru; Jackie S McGhie; Annemien E van den Bosch; Osama I Soliman; Kadir Caliskan
Journal:  Echocardiography       Date:  2021-12-08       Impact factor: 1.874

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.